Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda

<p>Abstract</p> <p>Background</p> <p>Among patients with HIV infection, depression is the most frequently observed psychiatric disorder. The presence of depressive symptoms and cognitive dysfunction among HIV patients has not been well studied in Sub-Saharan Africa. Ini...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Ronald Allan, Robertson Kevin, Allebeck Peter, Musisi Seggane, L Skolasky Richard, Nakasujja Noeline, Katabira Elly, Clifford David B, Sacktor Ned
Materialtyp: Artikel
Språk:English
Publicerad: BMC 2010-06-01
Serie:BMC Psychiatry
Länkar:http://www.biomedcentral.com/1471-244X/10/44
_version_ 1831542397505372160
author Ronald Allan
Robertson Kevin
Allebeck Peter
Musisi Seggane
L Skolasky Richard
Nakasujja Noeline
Katabira Elly
Clifford David B
Sacktor Ned
author_facet Ronald Allan
Robertson Kevin
Allebeck Peter
Musisi Seggane
L Skolasky Richard
Nakasujja Noeline
Katabira Elly
Clifford David B
Sacktor Ned
author_sort Ronald Allan
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Among patients with HIV infection, depression is the most frequently observed psychiatric disorder. The presence of depressive symptoms and cognitive dysfunction among HIV patients has not been well studied in Sub-Saharan Africa. Initiation of highly active antiretroviral therapy (HAART) may have an effect on the prevalence and the change over time of depression symptoms and cognitive impairment among HIV-positive individuals.</p> <p>Methods</p> <p>We recruited 102 HIV-positive individuals at risk of cognitive impairment who were initiating HAART and 25 HIV-negative individuals matched for age and education. Depression was assessed using the Centre for Epidemiologic Studies Depression Scale (CES-D). Neurocognitive assessment included the International HIV Dementia Scale (IHDS), an 8 test neuropsychological battery and the Memorial Sloan Kettering scale. Assessments were carried out at 0, 3 and 6 months.</p> <p>Results</p> <p>The HIV-positive group had more respondents with CES-D score > 16 than the HIV-negative group at all 3 clinic visits (54%Vs 28%; 36% Vs 13%; and 30% Vs 24% respectively; all p < 0.050 OR 2.86, 95% CI: 1.03, 7.95, p = 0.044). The HIV positive group had higher likelihood for cognitive impairment (OR 8.88, 95% CI 2.64, 29.89, p < 0.001). A significant decrease in the mean scores on the CES-D (p = 0.002) and IHDS (p = 0.001) occurred more in the HIV-positive group when compared to the HIV-negative group. There was no association between clinical Memorial Sloan Kettering score and depression symptoms (p = 0.310) at baseline.</p> <p>Conclusion</p> <p>Depression symptomatology is distinct and common among cognitively impaired HIV patients. Therefore individuals in HIV care should be screened and treated for depression.</p>
first_indexed 2024-12-17T00:33:27Z
format Article
id doaj.art-e724c3e78358435c9d5c08d4f43e5516
institution Directory Open Access Journal
issn 1471-244X
language English
last_indexed 2024-12-17T00:33:27Z
publishDate 2010-06-01
publisher BMC
record_format Article
series BMC Psychiatry
spelling doaj.art-e724c3e78358435c9d5c08d4f43e55162022-12-21T22:10:13ZengBMCBMC Psychiatry1471-244X2010-06-011014410.1186/1471-244X-10-44Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in UgandaRonald AllanRobertson KevinAllebeck PeterMusisi SegganeL Skolasky RichardNakasujja NoelineKatabira EllyClifford David BSacktor Ned<p>Abstract</p> <p>Background</p> <p>Among patients with HIV infection, depression is the most frequently observed psychiatric disorder. The presence of depressive symptoms and cognitive dysfunction among HIV patients has not been well studied in Sub-Saharan Africa. Initiation of highly active antiretroviral therapy (HAART) may have an effect on the prevalence and the change over time of depression symptoms and cognitive impairment among HIV-positive individuals.</p> <p>Methods</p> <p>We recruited 102 HIV-positive individuals at risk of cognitive impairment who were initiating HAART and 25 HIV-negative individuals matched for age and education. Depression was assessed using the Centre for Epidemiologic Studies Depression Scale (CES-D). Neurocognitive assessment included the International HIV Dementia Scale (IHDS), an 8 test neuropsychological battery and the Memorial Sloan Kettering scale. Assessments were carried out at 0, 3 and 6 months.</p> <p>Results</p> <p>The HIV-positive group had more respondents with CES-D score > 16 than the HIV-negative group at all 3 clinic visits (54%Vs 28%; 36% Vs 13%; and 30% Vs 24% respectively; all p < 0.050 OR 2.86, 95% CI: 1.03, 7.95, p = 0.044). The HIV positive group had higher likelihood for cognitive impairment (OR 8.88, 95% CI 2.64, 29.89, p < 0.001). A significant decrease in the mean scores on the CES-D (p = 0.002) and IHDS (p = 0.001) occurred more in the HIV-positive group when compared to the HIV-negative group. There was no association between clinical Memorial Sloan Kettering score and depression symptoms (p = 0.310) at baseline.</p> <p>Conclusion</p> <p>Depression symptomatology is distinct and common among cognitively impaired HIV patients. Therefore individuals in HIV care should be screened and treated for depression.</p>http://www.biomedcentral.com/1471-244X/10/44
spellingShingle Ronald Allan
Robertson Kevin
Allebeck Peter
Musisi Seggane
L Skolasky Richard
Nakasujja Noeline
Katabira Elly
Clifford David B
Sacktor Ned
Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda
BMC Psychiatry
title Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda
title_full Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda
title_fullStr Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda
title_full_unstemmed Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda
title_short Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda
title_sort depression symptoms and cognitive function among individuals with advanced hiv infection initiating haart in uganda
url http://www.biomedcentral.com/1471-244X/10/44
work_keys_str_mv AT ronaldallan depressionsymptomsandcognitivefunctionamongindividualswithadvancedhivinfectioninitiatinghaartinuganda
AT robertsonkevin depressionsymptomsandcognitivefunctionamongindividualswithadvancedhivinfectioninitiatinghaartinuganda
AT allebeckpeter depressionsymptomsandcognitivefunctionamongindividualswithadvancedhivinfectioninitiatinghaartinuganda
AT musisiseggane depressionsymptomsandcognitivefunctionamongindividualswithadvancedhivinfectioninitiatinghaartinuganda
AT lskolaskyrichard depressionsymptomsandcognitivefunctionamongindividualswithadvancedhivinfectioninitiatinghaartinuganda
AT nakasujjanoeline depressionsymptomsandcognitivefunctionamongindividualswithadvancedhivinfectioninitiatinghaartinuganda
AT katabiraelly depressionsymptomsandcognitivefunctionamongindividualswithadvancedhivinfectioninitiatinghaartinuganda
AT clifforddavidb depressionsymptomsandcognitivefunctionamongindividualswithadvancedhivinfectioninitiatinghaartinuganda
AT sacktorned depressionsymptomsandcognitivefunctionamongindividualswithadvancedhivinfectioninitiatinghaartinuganda